Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Porta

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancerConrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
Radiology. Imaging Cancer|September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with MyelomaChristina Messiou, Nuria Porta, Bhupinder Sharma, et al.
BJU International|March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerA Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
European Radiology|May 6, 2026
Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancyHardeep Singh Kalsi, Kristofer Linton-Reid, Changhyun Kim, et al.
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
Ebiomedicine|February 22, 2024
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialTim A D Smith, Catharine M L West, Nuradh Joseph, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal CancerMichael J Dubec, James Price, Michael Berks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2023
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancerMichael J Dubec, David L Buckley, Michael Berks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancerConrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
Radiology. Imaging Cancer|September 24, 2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with MyelomaChristina Messiou, Nuria Porta, Bhupinder Sharma, et al.
BJU International|March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerA Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.
European Radiology|May 6, 2026
Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancyHardeep Singh Kalsi, Kristofer Linton-Reid, Changhyun Kim, et al.
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
Ebiomedicine|February 22, 2024
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialTim A D Smith, Catharine M L West, Nuradh Joseph, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal CancerMichael J Dubec, James Price, Michael Berks, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2023
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancerMichael J Dubec, David L Buckley, Michael Berks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
Pageof 6